{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:54:24Z","timestamp":1787759664132,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04274-x","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:05:03Z","timestamp":1771830303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the proliferative role and prognostic value of GPR173 in gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Lingchen","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"10494","key":"4274_CR1","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(25)00052-2","volume":"405","author":"R Sundar","year":"2025","unstructured":"Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY, Smyth EC. Gastric cancer. Lancet. 2025;405(10494):2087\u2013102.","journal-title":"Lancet"},{"issue":"9","key":"4274_CR2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1136\/gutjnl-2022-328514","volume":"72","author":"M Rugge","year":"2023","unstructured":"Rugge M, Genta RM, Malfertheiner P, Graham DY. Steps forward in understanding gastric cancer risk. Gut. 2023;72(9):1802\u20133.","journal-title":"Gut"},{"issue":"Pt 3","key":"4274_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","volume":"86","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86(Pt 3):566\u201382.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"4274_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10(7):627\u201342.","journal-title":"Trends Cancer"},{"key":"4274_CR5","doi-asserted-by":"publisher","first-page":"116310","DOI":"10.1016\/j.biopha.2024.116310","volume":"173","author":"J Liu","year":"2024","unstructured":"Liu J, Yuan Q, Guo H, Guan H, Hong Z, Shang D. Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives. Biomed Pharmacother. 2024;173:116310.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4274_CR6","doi-asserted-by":"publisher","first-page":"189277","DOI":"10.1016\/j.bbcan.2025.189277","volume":"1880","author":"J Song","year":"2025","unstructured":"Song J, Zhu J, Jiang Y, Guo Y, Liu S, Qiao Y, Du Y, Li J. Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies. Biochim Biophys Acta Rev Cancer. 2025;1880(2):189277.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"4274_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstrom","year":"2008","unstructured":"Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008;7(4):339\u201357.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4274_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrd3320","volume":"10","author":"R Lappano","year":"2011","unstructured":"Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011;10(1):47\u201360.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"4274_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","volume":"19","author":"D Wootten","year":"2018","unstructured":"Wootten D, Christopoulos A, Marti-Solano M, Babu MM, Sexton PM. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol. 2018;19(10):638\u201353.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4274_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc2069","volume":"7","author":"RT Dorsam","year":"2007","unstructured":"Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7(2):79\u201394.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4274_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2015.10.003","volume":"28","author":"Y Hayakawa","year":"2015","unstructured":"Hayakawa Y, Ariyama H, Stancikova J, Sakitani K, Asfaha S, Renz BW, Dubeykovskaya ZA, Shibata W, Wang H, Westphalen CB, et al. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche. Cancer Cell. 2015;28(6):800\u201314.","journal-title":"Cancer Cell"},{"key":"4274_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2017.10.003","volume":"412","author":"J Chen","year":"2018","unstructured":"Chen J, Li GQ, Zhang L, Tang M, Cao X, Xu GL, Wu YZ. Complement C5a\/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Cancer Lett. 2018;412:30\u20136.","journal-title":"Cancer Lett"},{"issue":"10","key":"4274_CR13","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1158\/0008-5472.CAN-20-0066","volume":"81","author":"J Pi","year":"2021","unstructured":"Pi J, Wang W, Ji M, Wang X, Wei X, Jin J, Liu T, Qiang J, Qi Z, Li F, et al. YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7. Cancer Res. 2021;81(10):2651\u201365.","journal-title":"Cancer Res"},{"issue":"1","key":"4274_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9(1):88.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"4274_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser AS, Attwood MM, Rask-Andersen M, Schioth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017;16(12):829\u201342.","journal-title":"Nat Rev Drug Discov"},{"key":"4274_CR16","doi-asserted-by":"publisher","first-page":"113777","DOI":"10.1016\/j.ejmech.2021.113777","volume":"225","author":"T Pillaiyar","year":"2021","unstructured":"Pillaiyar T, Rosato F, Wozniak M, Blavier J, Charles M, Laschet C, Kronenberger T, Muller CE, Hanson J. Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27. Eur J Med Chem. 2021;225:113777.","journal-title":"Eur J Med Chem"},{"key":"4274_CR17","doi-asserted-by":"publisher","first-page":"108217","DOI":"10.1016\/j.pharmthera.2022.108217","volume":"240","author":"C Staubert","year":"2022","unstructured":"Staubert C, Wozniak M, Dupuis N, Laschet C, Pillaiyar T, Hanson J. Superconserved receptors expressed in the brain: Expression, function, motifs and evolution of an orphan receptor family. Pharmacol Ther. 2022;240:108217.","journal-title":"Pharmacol Ther"},{"issue":"Database issue","key":"4274_CR18","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database issue):D991\u2013995.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4274_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"N Research","year":"2013","unstructured":"Cancer Genome Atlas, Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"D1","key":"4274_CR20","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4274_CR21","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","volume":"49","author":"C Gene Ontology","year":"2021","unstructured":"Gene Ontology C. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 2021;49(D1):D325\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4274_CR22","doi-asserted-by":"publisher","first-page":"102202","DOI":"10.1016\/j.labinv.2024.102202","volume":"105","author":"G Zhang","year":"2025","unstructured":"Zhang G, Qu W, Huang X, Yi J, Gao H, He J, Xue W. HECW1-Mediated Ubiquitination of HIPK2 Drives Metastasis in Gastric Cancer Through the AKT Signaling Pathway. Lab Invest. 2025;105(2):102202.","journal-title":"Lab Invest"},{"issue":"1","key":"4274_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12935-024-03359-5","volume":"24","author":"Y Hu","year":"2024","unstructured":"Hu Y, Zang W, Feng Y, Mao Q, Chen J, Zhu Y, Xue W. mir-605-3p prevents liver premetastatic niche formation by inhibiting angiogenesis via decreasing exosomal nos3 release in gastric cancer. Cancer Cell Int. 2024;24(1):184.","journal-title":"Cancer Cell Int"},{"key":"4274_CR24","doi-asserted-by":"publisher","first-page":"1469180","DOI":"10.3389\/fphar.2024.1469180","volume":"15","author":"J He","year":"2024","unstructured":"He J, Li M, Bao J, Peng Y, Xue W, Chen J, Zhao J. beta-Elemene promotes ferroptosis and reverses radioresistance in gastric cancer by inhibiting the OTUB1-GPX4 interaction. Front Pharmacol. 2024;15:1469180.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4274_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Hu K, Cai X, Yang B, He Q, Wang J, Weng Q. Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B. 2022;12(1):18\u201332.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4274_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","volume":"6","author":"C Xue","year":"2021","unstructured":"Xue C, Li G, Lu J, Li L. Crosstalk between circRNAs and the PI3K\/AKT signaling pathway in cancer progression. Signal Transduct Target Ther. 2021;6(1):400.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4274_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009;9(8):550\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4274_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1541-7786.MCR-25-0389","volume":"24","author":"NF Downing","year":"2026","unstructured":"Downing NF, Mills KM, Hollenhorst PC. PRC2\/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma. Mol Cancer Res. 2026;24(1):48\u201359.","journal-title":"Mol Cancer Res"},{"key":"4274_CR29","doi-asserted-by":"publisher","first-page":"115900","DOI":"10.1016\/j.biopha.2023.115900","volume":"169","author":"M Ebrahimnezhad","year":"2023","unstructured":"Ebrahimnezhad M, Natami M, Bakhtiari GH, Tabnak P, Ebrahimnezhad N, Yousefi B, Majidinia M. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer. Biomed Pharmacother. 2023;169:115900.","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"4274_CR30","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-09-2990","volume":"16","author":"S Zhang","year":"2010","unstructured":"Zhang S, Yu D. PI(3)king apart PTEN\u2019s role in cancer. Clin Cancer Res. 2010;16(17):4325\u201330.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4274_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","volume":"122","author":"JM Beaulieu","year":"2005","unstructured":"Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 2005;122(2):261\u201373.","journal-title":"Cell"},{"issue":"1","key":"4274_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/1541-7786.MCR-24-0660","volume":"23","author":"JE Ippolito","year":"2025","unstructured":"Ippolito JE, Hartig JP, Bejar K, Nakhoul H, Sehn JK, Weimholt C, Grimsley G, Nunez E, Trikalinos NA, Chatterjee D, et al. N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype. Mol Cancer Res. 2025;23(1):59\u201370.","journal-title":"Mol Cancer Res"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04274-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04274-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04274-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:59:02Z","timestamp":1774882742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04274-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4274"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04274-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Affiliated Hospital of Nantong University(2023-K076-01), and all patients provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}